comparemela.com

Latest Breaking News On - Md main line health lankenau heart institute - Page 1 : comparemela.com

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

Prominent trialists took issue with the primary endpoint, how it was powered, and what effect COVID-19 and Katsanos played.

United-kingdom
Germany
Bad-krozingen
Baden-wüberg
New-zealand
Uppsala
Uppsala-lan
Sweden
Boston
Massachusetts
United-states
Charing-cross

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Experts at ISET 2024 made the case for IVUS, but given how slow uptake has been in the coronary space, the mood was a bit skeptical.

Miami
Florida
United-states
Miami-beach
New-york
Beth-israel-medical-center
Arnsberg
Nordrhein-westfalen
Germany
Boston
Massachusetts
German

New Carotid Stent Systems Associated With Low Stroke Risk

With complication rates of 1% or less, Neuroguard and CGuard are renewing optimism about CAS, experts said at VIVA 2023.

San-francisco
California
United-states
Raghu-kolluri
Williama-gray
Peter-schneider
Sean-lyden
D-christopher-metzger
Daniel-clair
Md-vanderbilt-university-medical-center
Md-main-line-health-lankenau-heart-institute
Drug-administration

Paclitaxel Safety Questions in PAD: Will 'Capstone' Data Close the Door?

After nearly 5 years, most at a TCT 2023 session agreed that the mystery of the paclitaxel signal has been solved.

New-york
United-states
Massachusetts
Greece
Italy
Boston
Stanford-university
California
San-francisco
Germany
Japan
Juan-granada

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

Adoption of IVL in the PAD space is likely to mirror the swift uptake seen in the coronaries, one panelist noted.

Wynnewood
Pennsylvania
United-states
Germany
New-york
Austria
New-zealand
Philadelphia
Williama-gray
Jennifera-rymer
Danielm-kolansky

vimarsana © 2020. All Rights Reserved.